$13.10
0.090.69%
At close: -
$13.00
-0.1-0.76%
After Hours: Dec 19, 7:00 PM EDT
Takeda Pharmaceutical Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Takeda Pharmaceutical Co using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $0.45 | $0.57 | -21.1 % |
Sep 2020 | 2020-10-29 | $0.47 | $0.98 | -52.0 % |
Mar 2020 | 2020-05-13 | $0.12 | $0.43 | -72.1 % |
Dec 2019 | 2020-02-04 | $0.53 | $0.32 | 65.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2020 | 2020-10-29 | $7.47B | $7.56M | 98722.8 % |
Mar 2020 | 2020-05-13 | $7.08B | $7.48M | 94539.0 % |
Dec 2019 | 2020-02-04 | $7.91B | $8.14M | 97025.3 % |
Takeda Pharmaceutical Co (TAK) is scheduled to report earnings on January 30, 2025. The last reported earnings were for reported on October 31, 2024 for Q2.
The Actual EPS was $0.45, which missed the estimate of $0.57.
The Actual Revenue was $7.9B, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.